Teeple, A, and E Muser. “Cost Per Responder Analysis of Guselkumab Versus Adalimumab Using Efficacy Results Fromm a Head-to-Head Clinical Trial in Patients With Moderate to Severe Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine 1, no. 3.1 (October 27, 2017): s6. Accessed April 19, 2024. https://www.jofskin.org/index.php/skin/article/view/157.